2025年肺癌基础和翻译研究的进展 - 概述和观点,重点关注NSCLC
Celine Mascaux1, Triparna Sen2, Montse Sanchez-Cespedes3
1Department of Pulmonology, University Hospital of Strasbourg, Strasbourg, France; Institut National De La Santé et De La Recherche Médicale (INSERM), Unité Mixte de Recherche (UMR)_1260, Regenerative Nanomedicine (NanoRegMed), Strasbourg University, Strasbourg, France.
概括
肺癌研究促进了对分子风险因素和过程的理解. 未来的研究将专注于改善生存结果和开发晚期肺癌的治疗疗法.
科学领域:
- 胸部瘤学的基础和转化科学.
- 肺癌发展和进展的分子机制.
背景情况:
- 肺癌研究正在迅速推进,改善了早期检测,诊断和治疗个性化.
- 最近的突破深化了对肺癌分子基因组学,蛋白质组学,病变发生和细胞生物学的理解.
研究的目的:
- 突出目前关于非小细胞肺癌 (NSCLC) 的研究.
- 专注于分子风险因素和肺癌中的关键生物过程.
- 确定未来的研究方向,以改善患者的生存率和治愈疗法.
主要方法:
- 审查目前的肺癌基础和转化研究.
- 专注于分子风险因素,瘤发生,异质性,表型可塑性,代谢重编程,免疫生物学,免疫微环境和微生物群.
- 综合IASLC基础和翻译科学 (BaTS) 委员会发现的结果.
主要成果:
- 全面概述NSCLC的研究领域.
- 强调分子,细胞和环境因素在肺癌中的复杂相互作用.
- 确定未来调查的关键领域.
结论:
- 持续的基础和翻译研究对于推进肺癌治疗至关重要.
- 专注于已识别的领域的未来研究有望改善生存率和治愈治疗方法,特别是在晚期疾病中.
- 该IASLC BaTS委员会旨在指导未来的科学领导力胸部癌症研究.
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:21Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458